Asia-Pacific Intravenous (IV) Iron Drugs Market Analysis 2012-2017 and Forecast 2018-2023

April 2018 | 101 pages | ID: AF45D51411CEN
99Strategy

Abstracts

SNAPSHOT
The Asia-Pacific Intravenous (IV) Iron Drugs market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Intravenous (IV) Iron Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Ferric Carboxymaltose
• Iron Sucrose
• Iron Dextran
• Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• Sanofi US
• Allergan
• AMAG Pharmaceuticals
• Dalichi Sankyo
• Luitpold Pharmaceuticals
• Pharmacosmos
• Takeda Pharmaceutical

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Nephrology
• Gynecology & Obstetrics
• Gastroenterology
• Oncology
• Cardiology
• Others

Region Coverage (Regional Production, Demand & Forecast by Regions etc.):

• China
• Japan & Korea
• India
• Southeast Asia
• Oceania

Contents

1 INDUSTRY OVERVIEW

1.1 Intravenous (IV) Iron Drugs Industry
  1.1.1 Overview
  1.1.2 Development of Intravenous (IV) Iron Drugs
1.2 Market Segment
  1.2.1 By Product Type
  1.2.2 By Application
1.3 Asia-Pacific Overview

2 MAJOR COMPANIES LIST

2.1 Sanofi US (Company Profile, Products & Services, Sales Data etc.)
2.2 Allergan (Company Profile, Products & Services, Sales Data etc.)
2.3 AMAG Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.4 Dalichi Sankyo (Company Profile, Products & Services, Sales Data etc.)
2.5 Luitpold Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
2.6 Pharmacosmos (Company Profile, Products & Services, Sales Data etc.)
2.7 Takeda Pharmaceutical (Company Profile, Products & Services, Sales Data etc.)

3 MARKET COMPETITION

3.1 Company Competition
3.2 Regional Market by Company

4 INTRAVENOUS (IV) IRON DRUGS MARKET BY TYPE

4.1 By Type
  4.1.1 Ferric Carboxymaltose
  4.1.2 Iron Sucrose
  4.1.3 Iron Dextran
  4.1.4 Others
4.2 Market Size
4.3 Market Forecast

5 MARKET DEMAND

5.1 Demand Situation
  5.1.1 Demand in Nephrology
  5.1.2 Demand in Gynecology & Obstetrics
  5.1.3 Demand in Gastroenterology
  5.1.4 Demand in Oncology
  5.1.5 Demand in Cardiology
  5.1.6 Demand in Others
5.2 Regional Demand Comparison
5.3 Demand Forecast

6 REGION OPERATION

6.1 Regional Production
6.2 Regional Market
6.3 by Region
  6.3.1 China
    6.3.1.1 By Type
    6.3.1.2 By Application
  6.3.2 Japan & Korea
    6.3.2.1 By Type
    6.3.2.2 By Application
  6.3.3 India
    6.3.3.1 By Type
    6.3.3.2 By Application
  6.3.4 Southeast Asia
    6.3.4.1 By Type
    6.3.4.2 By Application
  6.3.5 Oceania
    6.3.5.1 By Type
    6.3.5.2 By Application
6.4 Regional Forecast

7 MARKETING & PRICE

7.1 Price and Margin
  7.1.1 Price Trends
  7.1.2 Factors of Price Change
  7.1.3 Manufacturers Gross Margin Analysis
7.2 Marketing Channel

8 UPSTREAM & COST

8.1 Upstream
8.2 Cost

9 INDUSTRY ENVIRONMENT

9.1 Policy
9.2 Economics
9.3 Sociology
9.4 Technology

10 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Segment of Intravenous (IV) Iron Drugs
Table Asia-Pacific Intravenous (IV) Iron Drugs Market 2012-2023, by Product Type, in USD Million
Table Application Segment of Intravenous (IV) Iron Drugs
Table Asia-Pacific Intravenous (IV) Iron Drugs Market 2012-2023, by Application, in USD Million
Table Sanofi US Overview List
Table Intravenous (IV) Iron Drugs Business Operation of Sanofi US (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Overview List
Table Intravenous (IV) Iron Drugs Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AMAG Pharmaceuticals Overview List
Table Intravenous (IV) Iron Drugs Business Operation of AMAG Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dalichi Sankyo Overview List
Table Intravenous (IV) Iron Drugs Business Operation of Dalichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Luitpold Pharmaceuticals Overview List
Table Intravenous (IV) Iron Drugs Business Operation of Luitpold Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharmacosmos Overview List
Table Intravenous (IV) Iron Drugs Business Operation of Pharmacosmos (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Overview List
Table Intravenous (IV) Iron Drugs Business Operation of Takeda Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Asia-Pacific Intravenous (IV) Iron Drugs Sales Revenue 2012-2017, by Company, in USD Million
Table Asia-Pacific Intravenous (IV) Iron Drugs Sales Revenue Share, by Company, in USD Million
Table Asia-Pacific Intravenous (IV) Iron Drugs Sales Volume 2012-2017, by Company, in Volume
Table Asia-Pacific Intravenous (IV) Iron Drugs Sales Volume Share 2012-2017, by Company, in Volume
Table Major Company List of Ferric Carboxymaltose
Table Major Company List of Iron Sucrose
Table Major Company List of Iron Dextran
Table Major Company List of Others
Table Asia-Pacific Intravenous (IV) Iron Drugs Market 2012-2017, by Type, in USD Million
Table Asia-Pacific Intravenous (IV) Iron Drugs Market 2012-2017, by Type, in Volume
Table Asia-Pacific Intravenous (IV) Iron Drugs Market Forecast 2018-2023, by Type, in USD Million
Table Asia-Pacific Intravenous (IV) Iron Drugs Market Forecast 2018-2023, by Type, in Volume
Table Intravenous (IV) Iron Drugs Demand in Nephrology, 2012-2017, in USD Million
Table Intravenous (IV) Iron Drugs Demand in Nephrology, 2012-2017, in Volume
Table Major Consumers in Nephrology
Table Intravenous (IV) Iron Drugs Demand in Gynecology & Obstetrics, 2012-2017, in USD Million
Table Intravenous (IV) Iron Drugs Demand in Gynecology & Obstetrics, 2012-2017, in Volume
Table Major Consumers in Gynecology & Obstetrics
Table Intravenous (IV) Iron Drugs Demand in Gastroenterology, 2012-2017, in USD Million
Table Intravenous (IV) Iron Drugs Demand in Gastroenterology, 2012-2017, in Volume
Table Major Consumers in Gastroenterology
Table Intravenous (IV) Iron Drugs Demand in Oncology, 2012-2017, in USD Million
Table Intravenous (IV) Iron Drugs Demand in Oncology, 2012-2017, in Volume
Table Major Consumers in Oncology
Table Intravenous (IV) Iron Drugs Demand in Cardiology, 2012-2017, in USD Million
Table Intravenous (IV) Iron Drugs Demand in Cardiology, 2012-2017, in Volume
Table Major Consumers in Cardiology
Table Intravenous (IV) Iron Drugs Demand in Others, 2012-2017, in USD Million
Table Intravenous (IV) Iron Drugs Demand in Others, 2012-2017, in Volume
Table Major Consumers in Others
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Intravenous (IV) Iron Drugs Demand Forecast 2018-2023, by Application, in USD Million
Table Intravenous (IV) Iron Drugs Demand Forecast 2018-2023, by Application, in Volume
Table Intravenous (IV) Iron Drugs Production 2012-2017, by Region, in USD Million
Table Intravenous (IV) Iron Drugs Production 2012-2017, by Region, in Volume
Table Asia-Pacific Intravenous (IV) Iron Drugs Market Size 2012-2017, by Region, in USD Million
Table Asia-Pacific Intravenous (IV) Iron Drugs Market Size 2012-2017, by Region, in Volume
Table China Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in USD Million
Table China Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in Volume
Table China Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in USD Million
Table China Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in Volume
Table Japan & Korea Intravenous (IV) Iron Drugs Market Size 2012-2017, by Country, in USD Million
Table Japan & Korea Intravenous (IV) Iron Drugs Market Size 2012-2017, by Country, in Volume
Table Japan Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in USD Million
Table Japan Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in Volume
Table Japan Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in USD Million
Table Japan Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in Volume
Table India Intravenous (IV) Iron Drugs Market Size 2012-2017, by Country, in USD Million
Table India Intravenous (IV) Iron Drugs Market Size 2012-2017, by Country, in Volume
Table India Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in USD Million
Table India Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in Volume
Table India Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in USD Million
Table India Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in Volume
Table Southeast Asia Intravenous (IV) Iron Drugs Market Size 2012-2017, by Country, in USD Million
Table Southeast Asia Intravenous (IV) Iron Drugs Market Size 2012-2017, by Country, in Volume
Table Southeast Asia Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in USD Million
Table Southeast Asia Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in Volume
Table Southeast Asia Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in USD Million
Table Southeast Asia Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in Volume
Table Oceania Intravenous (IV) Iron Drugs Market Size 2012-2017, by Country, in USD Million
Table Oceania Intravenous (IV) Iron Drugs Market Size 2012-2017, by Country, in Volume
Table Oceania Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in USD Million
Table Oceania Intravenous (IV) Iron Drugs Market Size 2012-2017, by Type, in Volume
Table Oceania Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in USD Million
Table Oceania Intravenous (IV) Iron Drugs Market Size 2012-2017, by Application, in Volume
Table Intravenous (IV) Iron Drugs Market Forecast 2018-2023, by Region, in USD Million
Table Intravenous (IV) Iron Drugs Market Forecast 2018-2023, by Region, in Volume
Table Price Factors List
Table Upstream Segment of Intravenous (IV) Iron Drugs

List Of Figures

LIST OF FIGURES

Figure Intravenous (IV) Iron Drugs Industry Chain Structure
Figure Asia-Pacific Intravenous (IV) Iron Drugs Market Size and Growth Rate 2012-2023
Figure China Intravenous (IV) Iron Drugs Market, by Company, in 2018
Figure Japan & Korea Intravenous (IV) Iron Drugs Market, by Company, in 2018
Figure India Intravenous (IV) Iron Drugs Market, by Company, in 2018
Figure Southeast Asia Intravenous (IV) Iron Drugs Market, by Company, in 2018
Figure Oceania Intravenous (IV) Iron Drugs Market, by Company, in 2018
Figure Asia-Pacific Intravenous (IV) Iron Drugs Market Growth 2012-2017, by Type, in USD Million
Figure Asia-Pacific Intravenous (IV) Iron Drugs Market Growth 2012-2017, by Type, in Volume
Figure China Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in USD Million
Figure China Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in Volume
Figure Japan & Korea Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in USD Million
Figure Japan & Korea Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in Volume
Figure India Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in USD Million
Figure India Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in Volume
Figure Southeast Asia Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in USD Million
Figure Southeast Asia Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in Volume
Figure Oceania Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in USD Million
Figure Oceania Intravenous (IV) Iron Drugs Market Size and Growth 2012-2017, in Volume
Figure Marketing Channels Overview